EXEL Industries: Second quarter 2024–2025 sales down 3.8% Q2 2024–2025 revenue: -3.8% Businesses proved to be resilient in an uncertain economic context Q2 sales(January 2025–March 2025)) 2023–2024 2024–2025 Change (reported) Change (LFL*) Reported Reported €m % €m % AGRICULTURAL SPRAYING 157.4 132.7 -24.7 -15.7% -25.2 -16.0% SUGAR BEET HARVESTING 17.1 25.3 +8.1 +47.6% +9.4 +54.7% LEISURE 47.4 47.3 -0.0 -0.1% -0.4 -0.8% INDUSTRY 70.7 76.0 +5.3 +7.5% +3.7 +5.2% EXEL Industries Group 292.6 281.4 -11.3 -3.8% -12.6 -4.3% Like-for-like ...
EXEL Industries : Chiffre d’affaires 2e trimestre 2024–2025 -3,8 % Chiffre d’affaires 2e trimestre 2024–2025 : - 3,8 % Bonne résistance des activités dans un contexte économique incertain Chiffre d'affaires T2(janvier 2025–mars 2025)) 2023–2024 2024–2025 Variation à données publiées Variation à tcpc* Publié Publié Millions € % Millions € % PULVÉRISATION AGRICOLE 157,4 132,7 - 24,7 - 15,7 % - 25,2 - 16,0 % ARRACHAGE DE BETTERAVES 17,1 25,3 + 8,1 + 47,6 % + 9,4 + 54,7 % LOISIRS 47,4 47,3 - 0,0 - 0,1 % - 0,4 - 0,8 % INDUSTRIE 70,7 76,0 + 5,3 + 7...
EXEL Industries: Total number of voting rights and shares at 03.31.2025 EXEL IndustriesA French Société Anonyme with a share capital of €16,969,750Registered office: 54, rue Marcel Paul - 51206 Epernay Cedex - FranceReims Companies Register (RCS): No. 095 550 356 Number of shares and voting rights Article 223-16 of the AMF regulation Date Total number of shares comprising the share capital Total number of voting rights March 31, 2025 6,787,900 Theoretical voting rights: 9,891,627 Exercisable voting rights*: 9,886,248 * After deduction of shares without voting ...
EXEL Industries : Nombre total de droits de vote et d’actions au 31.03.2025 EXEL IndustriesSociété Anonyme au capital de 16 969 750 €Siège social : 54, rue Marcel Paul 51206 Epernay CedexRCS Reims n° 095 550 356 Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital socialArticle 223-16 du Règlement Général de l’AMF Date Nombre total d’actionscomposant le capital social Nombre total de droits de vote 31 mars 2025 6 787 900 Droits de vote théoriques : 9 891 627 Droits de vote exerçables* : 9 886 248 * Déduction faite des acti...
Following preliminary results on its phase 2b trial evaluating AEF117 in CUD, which as a reminder failed to show statistically significant effects across the binary endpoints, which measured the absolute reduction in cannabis consumption, Aelis published the final analysis of the data set and provi
EXEL Industries: Total number of voting rights and shares at 02.28.2025 EXEL IndustriesA French Société Anonyme with a share capital of €16,969,750Registered office: 54, rue Marcel Paul - 51206 Epernay Cedex - FranceReims Companies Register (RCS): No. 095 550 356 Number of shares and voting rights Article 223-16 of the AMF regulation Date Total number of shares comprising the share capital Total number of voting rights February 28, 2025 6,787,900 Theoretical voting rights: 9,891,683 Exercisable voting rights*: 9,887,182 * After deduction of shares without voti...
EXEL Industries: Total number of voting rights and shares at 01.31.2025 EXEL IndustriesA French Société Anonyme with a share capital of €16,969,750Registered office: 54, rue Marcel Paul - 51206 Epernay Cedex - FranceReims Companies Register (RCS): No. 095 550 356 Number of shares and voting rights Article 223-16 of the AMF regulation Date Total number of shares comprising the share capital Total number of voting rights January 31, 2025 6,787,900 Theoretical voting rights: 9,891,683 Exercisable voting rights*: 9,887,644 * After deduction of shares without votin...
BORDEAUX, France--(BUSINESS WIRE)-- Regulatory News: Aelis Farma (ISIN : FR0014007ZB4 – Mnémonique : AELIS, éligible PEA-PME), société biopharmaceutique au stade clinique spécialisée dans le développement de traitements pour les maladies du cerveau et périphériques impliquant le récepteur CB1 du système endocannabinoïde, annonce aujourd’hui son calendrier financier indicatif pour l’exercice 2025. Évènement Date de publication* Résultats annuels 2024 Le mardi 1er avril 2025 Assemblée générale annuelle Le mardi 27 mai 2025 Résultats semestriels 2025 Le lundi 22 sep...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.